Bionova Capital is an independent,
healthcare-specialized venture capital firm, investing in early-stage life science companies.
Bionova Capital was founded in 2015 and was formerly known as Hovione Capital.
- Our team has deep expertise in company building and drug
development, and a track record investing in therapeutics, medtech and digital health.
- We invest in Europe, looking for opportunities in academia,
biotech, and pharmaceutical companies.
- We collaborate with exceptional entrepreneurs and provide
capital, expertise and access to a global network of resources to add operational, strategic and
financial value. We capitalize on our shareholders’ experience, who have successfully built a
60-year-old, profitable business in the global pharmaceutical industry.
- Before investing in a company, we perform a rigorous and
extensive due diligence process and help entrepreneurs improve their product development roadmap.